VERUS PHARMACEUTICALS DONATES 5,000 TWINJECT DEMONSTRATORS TO SUPPORT ANAPHYLAXIS DAY

Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, today announced it will donate 5,000 Twinject demonstrator devices for Anaphylaxis Day activities on March 5 during the 2006 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Anaphylaxis Day aims to educate physicians, health care professionals and the public about anaphylaxis, a severe, life-threatening systemic allergic reaction.

PR Newswire (http://www.prnewswire.com/cgibin/stories.pl?ACCT=104&STORY=/www/story/03-03-2006/0004313120&EDATE=)